Antiagrégants plaquettaires et diabète

Annales de Cardiologie et d'Angeiologie - Tập 59 - Trang S56-S64 - 2010
L. Drouet1, C. Bal dit Sollier2, P. Henry3
1Angio-hématologie, Hôpital Lariboisière, AP-HP Paris, Faculté de Médecine Paris VII, France
2Laboratoire de Thrombose et d’Athérosclérose, Institut des vaisseaux et du Sang, hôpital Lariboisière Paris, France
3Département de cardiologie, Hôpital Lariboisière, APHP Paris, Faculté de Médecine Paris VII, France

Tài liệu tham khảo

Krempf, 2010, Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry), Am J Cardiol, 105, 667, 10.1016/j.amjcard.2009.10.048

Belch, 2008, BMJ, 337, a1840, 10.1136/bmj.a1840

Ogawa, 2008, Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial, JAMA, 300, 2134, 10.1001/jama.2008.623

De Berardis, 2009, Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials, BMJ, 339, b4531, 10.1136/bmj.b4531

Baigent, 2009, Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, Lancet, 373, 1849, 10.1016/S0140-6736(09)60503-1

Cubbon, 2008, Aspirin and mortality in patients with diabetes sustaining acute coronary syndrome, Diabetes Care, 31, 363, 10.2337/dc07-1745

Cuisset, 2009, Aspirin noncompliance is the major cause of “aspirin resistance” in patients undergoing coronary stenting, Am Heart J, 157, 889, 10.1016/j.ahj.2009.02.013

Catella-Lawson, 2001, Cyclooxygenase inhibitors and the antiplatelet effects of aspirin, N Engl J Med, 345, 1809, 10.1056/NEJMoa003199

Henry P, Vermillet A, Boval B, Guyetand C, Petroni T, Dillinger JG, et al. 24-Hour Time Dependent Aspirin Efficacy in Patients with Stable Coronary Artery Disease. Thromb Haemost 2011 (in press).

Brown, 1997, Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis, Arterioscler Thromb Vasc Biol, 17, 802, 10.1161/01.ATV.17.4.802

Drissa A, Dillinger JG, Bal dit Sollier C, Sideris G, Stratiev V, Drouet L et al. Aspirin twice daily decreases biological aspirin resistance in type 2 diabetic patients with CAD. ESC 2010 Oral presentation 5038.

1996, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3

Dasgupta, 2009, Am J Cardiol, 103, 1359, 10.1016/j.amjcard.2009.01.342

Yusuf, 2001, Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N Engl J Med, 345, 494, 10.1056/NEJMoa010746

Harrington, 2008, Non-ST-Segment Elevation Acute Coronary Syndromes. American College of Chest Physicians Evidence Based Clinical Practice Guidelines (8th Edition), CHEST, 133, 670S, 10.1378/chest.08-0691

Wolff, 2009, Aspirin for the Primary Prevention of Cardiovascular Events: an update of the evidence for the U.S. preventive services task force, Rockville (MD): Agency for Healthcare Research and Quality (US);Mar

Angiolillo, 2007, Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study, Circ, 115, 708, 10.1161/CIRCULATIONAHA.106.667741

Mehta, 2010, Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT- OASIS 7): a randomised factorial trial, Lancet, 376, 1233, 10.1016/S0140-6736(10)61088-4

Wiviott, 2008, Circ, 118, 1626, 10.1161/CIRCULATIONAHA.108.791061

Wallentin, 2009, Ticagrelor versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 361, 1045, 10.1056/NEJMoa0904327

James J, Angiolillo DJ, Cornel JH, Erlinge D, Husted S, Kontny F, et al. Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J 2010 (in press).

Fontana, 2010, Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study, J Thromb Haemost, 10.1111/j.1538-7836.2010.04063.x

Thông tin
Thông tin xuất bản

Annales de Cardiologie et d'Angeiologie

Tập 59

S56-S64

Thông tin tác giả